BCYC
Price
$14.71
Change
-$0.29 (-1.93%)
Updated
Dec 20, 04:59 PM (EDT)
73 days until earnings call
XNCR
Price
$24.14
Change
+$0.13 (+0.54%)
Updated
Dec 20, 04:59 PM (EDT)
72 days until earnings call
Ad is loading...

BCYC vs XNCR

Header iconBCYC vs XNCR Comparison
Open Charts BCYC vs XNCRBanner chart's image
Bicycle Therapeutics
Price$14.71
Change-$0.29 (-1.93%)
Volume$4.49K
CapitalizationN/A
Xencor
Price$24.14
Change+$0.13 (+0.54%)
Volume$30.69K
CapitalizationN/A
BCYC vs XNCR Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. XNCR commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and XNCR is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (BCYC: $14.68 vs. XNCR: $24.13)
Brand notoriety: BCYC and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 54% vs. XNCR: 631%
Market capitalization -- BCYC: $1.01B vs. XNCR: $1.69B
BCYC [@Biotechnology] is valued at $1.01B. XNCR’s [@Biotechnology] market capitalization is $1.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 5 bearish.
  • XNCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а +6.30% price change this week, while XNCR (@Biotechnology) price change was +0.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 04, 2025.

XNCR is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($1.69B) has a higher market cap than BCYC($1.01B). XNCR YTD gains are higher at: 13.660 vs. BCYC (-18.805). BCYC has higher annual earnings (EBITDA): -160.02M vs. XNCR (-198.91M). BCYC has more cash in the bank: 891M vs. XNCR (543M). BCYC has less debt than XNCR: BCYC (11.1M) vs XNCR (86.6M). XNCR has higher revenues than BCYC: XNCR (85.2M) vs BCYC (36.9M).
BCYCXNCRBCYC / XNCR
Capitalization1.01B1.69B60%
EBITDA-160.02M-198.91M80%
Gain YTD-18.80513.660-138%
P/E RatioN/AN/A-
Revenue36.9M85.2M43%
Total Cash891M543M164%
Total Debt11.1M86.6M13%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCXNCR
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 1 day ago
72%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 9 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
69%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AREAX14.200.24
+1.72%
AB Global Real Estate Investment A
WFPCX42.940.47
+1.11%
Allspring Special Mid Cap Value C
PSBMX25.460.26
+1.03%
Principal SmallCap R3
NAWGX45.310.34
+0.76%
Voya Global High Dividend Low Vol A
FBSRX34.84-1.49
-4.09%
Franklin Mutual U.S. Mid Cap Value R

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RPTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-2.13%
RPTX - BCYC
45%
Loosely correlated
N/A
PHIO - BCYC
41%
Loosely correlated
+1.15%
RLAY - BCYC
40%
Loosely correlated
-2.23%
EDIT - BCYC
38%
Loosely correlated
-2.24%
SRRK - BCYC
36%
Loosely correlated
+6.44%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RLAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+0.50%
RLAY - XNCR
53%
Loosely correlated
-2.23%
VCYT - XNCR
52%
Loosely correlated
+4.66%
ERAS - XNCR
49%
Loosely correlated
+3.47%
PGEN - XNCR
45%
Loosely correlated
+5.07%
BEAM - XNCR
44%
Loosely correlated
+8.16%
More